Betahistine Dihydrochloride (SERC betahistine dihydrochloride 16 mg tablet blister pack)
Betahistine Dihydrochloride risk profile, scheduling, and guidance for claims professionals and care workers . Also known as SERC betahistine dihydrochloride 16 mg tablet blister pack, APO-BETAHISTINE betahistine dihydrochloride 16 mg uncoated tablet blister pack, BETAHISTINE SANDOZ betahistine dihydrochloride 16mg tablet blister pack.
Betahistine Dihydrochloride (brand names: SERC betahistine dihydrochloride 16 mg tablet blister pack, APO-BETAHISTINE betahistine dihydrochloride 16 mg uncoated tablet blister pack, BETAHISTINE SANDOZ betahistine dihydrochloride 16mg tablet blister pack) is classified as Low risk (1 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Vestibular disorder medication that may cause drowsiness affecting workplace safety.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Low (1 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | Not PBS listed |
Risk Profile
Vestibular disorder medication that may cause drowsiness affecting workplace safety.
Regulatory and Compliance Guidance
When Betahistine Dihydrochloride appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Need to assess this medication across your caseload?
Run a full risk assessment including Betahistine Dihydrochloride interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.